Nippon India Pharma Fund - Direct Plan - IDCW Option

Nippon India Mutual Fund · Sectoral/Thematic · Direct · IDCW

NAV · as of 11/09/2026

174.71

-0.22%

+2.60%

Key stats

Expense ratio: 1.00%
AUM: ₹9.48 K Cr
Launched: 01/01/2013
Fund manager: Sailesh Raj Bhan; Kinjal Desai; Amber Singhania
Portfolio turnover: 0.15%
Risk: Very High Risk
Min lump-sum: ₹5,000
Min SIP: ₹100/mo
Fresh lump-sum: Accepted
Fresh SIP: Accepted

NAV history

Nippon India Pharma Fund - Direct Plan - IDCW Option

13/08/2026 to 11/09/2026

O - H - L -

1W-0.58%

1M-1.39%

3M+5.57%

6M+13.26%

1Y+2.60%

3Y+10.17%

5Y+7.99%

MAX+269.44%

Top holdings

38 disclosed

1.
Sun Pharmaceuticals Industries Ltd
Healthcare
13.31%
2.
Lupin Ltd
Healthcare
7.25%
3.
Divi's Laboratories Ltd
Healthcare
6.52%
4.
Cipla Ltd
Healthcare
6.03%
5.
Apollo Hospitals Enterprise Ltd
Healthcare
5.30%
6.
Dr Reddy's Laboratories Ltd
Healthcare
5.01%
7.
Mankind Pharma Ltd
Healthcare
3.74%
8.
Sai Life Sciences Ltd
Healthcare
3.62%
9.
Ajanta Pharma Ltd
Healthcare
3.41%
10.
Max Healthcare Institute Ltd Ordinary Shares
Healthcare
3.15%
11.
Medplus Health Services Ltd
Healthcare
2.69%
12.
GlaxoSmithKline Pharmaceuticals Ltd
Healthcare
2.66%
13.
Ipca Laboratories Ltd
Healthcare
2.57%
14.
Thyrocare Technologies Ltd
Healthcare
2.51%
15.
Vijaya Diagnostic Centre Ltd
Healthcare
2.42%
16.
Abbott India Ltd
Healthcare
2.24%
17.
Triparty Repo
2.16%
18.
Gland Pharma Ltd
Healthcare
2.16%
19.
Piramal Pharma Ltd
Healthcare
2.09%
20.
Dr. Lal PathLabs Ltd
Healthcare
2.05%
21.
Alkem Laboratories Ltd
Healthcare
2.01%
22.
Narayana Hrudayalaya Ltd
Healthcare
1.80%
23.
Pfizer Ltd
Healthcare
1.65%
24.
Emcure Pharmaceuticals Ltd
Healthcare
1.58%
25.
Aurobindo Pharma Ltd
Healthcare
1.54%
26.
Syngene International Ltd
Healthcare
1.46%
27.
Fortis Healthcare Ltd
Healthcare
1.37%
28.
Sanofi India Ltd
Healthcare
1.07%
29.
Sanofi Consumer Healthcare India Ltd
Healthcare
1.06%
30.
Suraksha Diagnostic Ltd
Healthcare
1.06%
31.
Akums Drugs and Pharmaceuticals Ltd
Healthcare
1.00%
32.
Anthem Biosciences Ltd
Healthcare
0.92%
33.
Biocon Ltd
Healthcare
0.92%
34.
AstraZeneca Pharma India Ltd
Healthcare
0.55%
35.
Net Current Assets
0.51%
36.
Indoco Remedies Ltd
Healthcare
0.43%
37.
Concord Biotech Ltd
Healthcare
0.17%
38.
Cash Margin - Ccil
0.01%

Sector allocation

Healthcare97.32%
Unclassified2.68%

Comparable peers

SBI Healthcare Opportunities IDCW Reinvest Direct Plan
SBI Healthcare Opportunities IDCW Reinvest (DR) · ₹5.80 K Cr AUM
1Y+22.13%
3Y+24.61%
-
Nippon India Pharma IDCW Reinvest Direct Plan
Nippon India Pharma IDCW Reinvest (DR) · ₹9.48 K Cr AUM
1Y+10.09%
3Y+17.91%
-
HDFC Transportation & Logistics IDCW Reinvest Direct Plan
HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM
1Y+9.79%
3Y+25.46%
-
HDFC Transportation & Logistics IDCW Reinvest Direct Plan
HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM
1Y+9.79%
3Y+25.46%
-
HDFC Transportation & Logistics IDCW Payout Direct Plan
HDFC Transportation & Logistics IDCW Payout (DP) · ₹1.96 K Cr AUM
1Y+9.79%
3Y+25.46%
-

Investment objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Scheme details

Scheme code: 118756
Fund house: Nippon India Mutual Fund
Category: Open Ended
Type: Equity Schemes
Sub-category: Sectoral/Thematic
Plan: Direct
Return type: IDCW
ISIN (Growth): INF204K01I35
ISIN (Div. Reinvest): INF204K01I43
Tradable on exchange: No

Kuvera page